Dr. Leonardo Daniel Borregales, MD

Dr. Borregales practices at Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida.

Dr. Borregales' NPI, 1316391105, was assigned on April 18, 2016. Dr. Borregales graduated from Central University of Venezuela in 2013. Dr. Borregales holds Florida license ME162501.

Dr. Borregales' primary practice is Mount Sinai Medical Center, at 4300 Alton Rd, Miami Beach, FL 33140 in Miami-Dade County. The practice phone is (305) 674-2121.

Dr. Borregales' primary practice is Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida. Dr. Borregales is also affiliated with Lower Keys Medical Center. The medical group on file is Mount Sinai Medical Center. Dmand AI also links Dr. Borregales to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Borregales practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Borregales' primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Borregales is board certified in urology by the American Board of Urology. Dmand AI has Dr. Borregales' licenses on file in 2 states: Florida and New York.

Dmand AI lists enlarged prostate, kidney stone disease, urinary endoscopy and UTI among the conditions Dr. Borregales treats.

CMS data shows 416 Medicare services from Dr. Borregales across 13 procedure codes in 2024, for 178 Medicare patients. Medicare paid $29,592 for them.

CMS counts 178 Medicare patients who saw Dr. Borregales in 2024. The largest group is 65 to 74, with 71 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Borregales' median patient age at 70, with 18% women.

In 2024, Dr. Borregales wrote 492 Medicare Part D claims for 195 patients. 91% of them were for generic drugs. CMS names the drug for 383 of them, across 9 drugs with 11 or more claims each, at $18,319 in total drug cost. In 2023, CMS named 16 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Borregales for performance year 2024, reported as part of a group. Dr. Borregales accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Borregales as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 28 papers to Dr. Borregales, published from 2015 to 2024. 2022 was the busiest year, with 4. The most frequent topics are Carcinoma, Renal Cell, Kidney Neoplasms and Nephrectomy. Dr. Borregales has published most often in Urol Oncol. Dr. Borregales' most frequent co-authors are Mehrad Adibi, MD, Jim C. Hu, MD, MPH and Jose Antonio Karam, MD.

CMS Open Payments shows 93 general payments to Dr. Borregales from 31 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 51% of the total. AngioDynamics, Inc. paid the most, $2,356.

Dr. Borregales graduated from Central University of Venezuela in 2013.

Dr. Borregales is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.